Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 5:6:5.
doi: 10.1038/s41523-020-0146-2. eCollection 2020.

Association between low estrogen receptor positive breast cancer and staining performance

Affiliations

Association between low estrogen receptor positive breast cancer and staining performance

Dennis Caruana et al. NPJ Breast Cancer. .

Abstract

Estrogen receptor (ER) expression in breast carcinomas, determined by immunohistochemistry, indicates statistically significant benefit to endocrine therapy in patients with tumors expressing ER in ≥1% of tumor cells. Rare cases with low ER expression (1-10%) lead to the dilemma of treating these tumors as ER positive or negative. We hypothesize that low ER positive result from poor staining performance and that we may detect this artefact by assessing the average dynamic range of normal ducts adjacent to low ER positive tumors. Using quantitative tools, we compare the dynamic range of normal background ER expression in patients with low (1-10%) ER tumors to dynamic range of ER expression in normal epithelium from control patient populations, to determine if low ER cases are accompanied by decreased dynamic range. Low ER cases were infrequent (1% of invasive breast carcinomas). Twenty-one cases with low ER staining and two control cohorts, including a tissue microarray (TMA) of 10 benign breast sections and a group of 34 control breast carcinomas (reported as ER negative or >10% ER positive) with normal background epithelium, were digitally scanned. QuPath was utilized to quantify ER staining for each cell as the mean optical density of nuclear DAB staining. The dynamic range of ER expression in normal epithelium surrounding low ER tumors was significantly lower (range 2-240, median 16.5) than that of the benign epithelium in the control tumors (range 3-475, median 30.8; p < 0.001) and benign TMA sections (range 38-212, median 114; p < 0.001) suggesting inconsistent stainer performance.

Keywords: Breast cancer; Predictive markers; Tumour biomarkers.

PubMed Disclaimer

Conflict of interest statement

Competing interestsD.R. works or has worked as a consultant to AstraZeneca, Agendia, Agilent, Amgen, Biocept, BMS, Cell Signaling Technology, Cepheid, Diiachi Sankyo, Merck, NanoString, Perkin Elmer, and Ultivue; has equity in PixelGear; and received research funding from AstraZeneca, Cepheid, Lilly, Navigate/Novartis, NextCure, NanoString, Ultivue, and Perkin Elmer. The remaining authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Consort diagram of clinical case selection.
Fig. 2
Fig. 2. Mean Nuclear OD in Low ER and control groups.
The mean nuclear OD values were log transformed. Cases of Low ER (1–10% staining) are compared to normal epithelium in the matched clinical full section control cases and in core tissue on YTMA-55. The lower and upper bars represent the minimum and maximum, respectively; the lower and upper edges of the box represent the 25th and 75th percentiles, respectively; the line in the middle of the box represents the median; the gray dots represent log transformed mean nuclear OD values.
Fig. 3
Fig. 3. Cell detection and ER quantification on normal ducts using the open-source platform QuPath.
a Non-neoplastic breast duct epithelium manually demarcated on a whole-slide image, outlined in yellow. b Initial detection of luminal nuclei circled in red. c Following manual elimination of objects deemed to represent non-luminal nuclei or incorrect partitioning of luminal nuclei. d Dynamic range of ER expression plotted with each bar representing the mean DAB for individual nuclei (*100) and the red bar representing the lowest limit of detection. OD = optical density.

References

    1. Goldstein NS, Ferkowicz M, Odish E, Mani A, Hastah F. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am. J. Clin. Pathol. 2003;120:86–92. doi: 10.1309/QPHDRB00QXGMUQ9N. - DOI - PubMed
    1. Layfield LJ, Goldstein N, Perkinson KR, Proia AD. Interlaboratory variation in results from immunohistochemical assessment of estrogen receptor status. Breast J. 2003;9:257–259. doi: 10.1046/j.1524-4741.2003.09325.x. - DOI - PubMed
    1. Nkoy FL, et al. Variable specimen handling affects hormone receptor test results in women with breast cancer: a large multihospital retrospective study. Arch. Pathol. Lab Med. 2010;134:606–612. - PubMed
    1. Rhodes A, et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Am. J. Clin. Pathol. 2001;115:44–58. doi: 10.1309/H905-HYC1-6UQQ-981P. - DOI - PubMed
    1. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD. Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J. Clin. Pathol. 2000;53:688–696. doi: 10.1136/jcp.53.9.688. - DOI - PMC - PubMed